Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy

PURPOSE: Immunotherapy against immune checkpoints has significantly improved survival both in metastatic and adjuvant setting in several types of cancers. Thyroid dysfunction is the most common endocrine adverse event reported. Patients who are at risk of developing thyroid dysfunction remain to be...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Endocrinol Invest
Egile Nagusiak: Brilli, L., Danielli, R., Campanile, M., Secchi, C., Ciuoli, C., Calabrò, L., Pilli, T., Cartocci, A., Pacini, F., Di Giacomo, A. M., Castagna, M. G.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2020
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285335/
https://ncbi.nlm.nih.gov/pubmed/33367977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40618-020-01480-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak